Medicalg (MDG) — Capital Reinvestment Ratio

Latest as of September 2023: 6.53x

Medicalg (MDG) has a Capital Reinvestment Ratio of 6.53x as of September 2023, meaning it reinvests 7% of its operating cash flow (zł392.00K) in capital expenditures (zł2.56 Million). See Medicalg balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

6.53x
Capex / Operating Cash Flow

Operating Cash Flow

zł392.00K
PLN

Capital Expenditures

zł2.56 Million
PLN

Data as of

Sep 2023
Most recent filing

Medicalg Capital Reinvestment Ratio (2011–2023)

This chart tracks Medicalg's Capital Reinvestment Ratio across 10 annual periods. Check MDG cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Medicalg (2011–2023)

Year-by-year Capital Reinvestment Ratio for Medicalg from 2011 to 2023. For live market cap and broader valuation context, see Medicalg market capitalisation.

Year Reinvestment Ratio Operating CF (PLN) Capital Expenditures YoY Change
2023 62.19x zł182.00K zł11.32 Million ▲ +3082.0%
2022 1.95x zł6.33 Million zł12.37 Million ▲ +201.7%
2019 0.65x zł13.50 Million zł8.74 Million ▲ +345.4%
2018 0.15x zł44.23 Million zł6.43 Million ▼ -89.0%
2017 1.32x zł28.61 Million zł37.83 Million ▲ +452.7%
2016 0.24x zł35.48 Million zł8.49 Million ▲ +54.1%
2015 0.16x zł17.35 Million zł2.69 Million ▲ +278.1%
2013 0.04x zł5.58 Million zł229.00K ▼ -18.0%
2012 0.05x zł4.11 Million zł205.84K ▼ -85.6%
2011 0.35x zł2.69 Million zł933.56K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow